Skip to content

Author

Alexander V. Kabanov

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Nanoparticle Co-delivery of Microtubule Inhibitors and Cisplatin Overcomes DNA Repair-Mediated Resistance in Head and Neck Cancer.

Cisplatin remains a crucial chemotherapeutic for head and neck squamous cell carcinoma (HNSCC), but its effectiveness is limited by intrinsic or acquired resistance driven largely by enhanced DNA crosslink repair. Through a combined screen of DNA crosslink repair and cisplatin sensitivity modulators, our current study...

Xin Li, L. Palchak, Ling Wang et al. · 0 citations
Open access Aug 2026

Poly(2-oxazoline) Micelles for Co-Delivery of Paclitaxel and Metronidazole Benzoate for Dual Chemotherapeutic and Antibacterial Targeting in the Tumor Microenvironment

A poly(2-oxazoline) micelle (POx) platform co-encapsulating paclitaxel (PTX) and metronidazole benzoate (MB) to achieve concurrent delivery of anticancer and antibacterial agents is reported, highlighting the potential of POx micelles as a versatile platform for targeting both cancer cells and tumor-associated pathogen...

Alyssa Holden, Hallie Hutsell, L. Palchak et al. · 0 citations
Review Open access Sep 2026

Nanomedicine beyond carriers — devices, cells & living therapeutics

This perspective summarizes the current landscape of biomedical nanotechnologies and outlines how their continued evolution positions nanomedicine as an enabling science driving the next generation of therapeutics.

A. Grattoni, Marco M. Paci, Noah Arnold et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.